human | Q5 |
P734 | family name | Burwinkel | Q37489243 |
Burwinkel | Q37489243 | ||
Burwinkel | Q37489243 | ||
P101 | field of work | metabolomics | Q12149006 |
P735 | given name | Barbara | Q153957 |
Barbara | Q153957 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q56836084 | 40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004 |
Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q51569689 | A BRCA1 promoter variant (rs11655505) and breast cancer risk. |
Q46462920 | A bias in genotyping the ERBB2 (HER2) Ile655Val variant |
Q37313778 | A breast cancer risk haplotype in the caspase-8 gene |
Q84920409 | A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk |
Q37332232 | A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q33368134 | A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults |
Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
Q92152049 | A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival |
Q53651538 | A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients. |
Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
Q53315710 | A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. |
Q52605797 | A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk. |
Q28237116 | ARLTS1 variants and melanoma risk |
Q57192440 | ARLTS1 variants and risk of colorectal cancer |
Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
Q33279172 | Allelotyping of pooled DNA with 250 K SNP microarrays |
Q52937376 | Arthrogryposis multiplex with deafness, inguinal hernias, and early death: a family report of a probably autosomal recessive trait. |
Q56987646 | Association Between Functional FABP2 Promoter Haplotype and Type 2 Diabetes |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q94355861 | Association of () polymorphisms with breast cancer risk |
Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
Q46402532 | Association of NCOA3 polymorphisms with breast cancer risk |
Q46707380 | Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis |
Q44471824 | Association of acyl-CoA-binding protein (ACBP) single nucleotide polymorphisms and type 2 diabetes in two German study populations |
Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
Q54657396 | Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk. |
Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
Q51836207 | Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer. |
Q54620954 | Association of prolactin and its receptor gene regions with familial breast cancer. |
Q53651814 | Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q28240593 | Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer |
Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
Q33284720 | BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study |
Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
Q39465495 | CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer |
Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
Q42917130 | Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures |
Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
Q28655235 | Capture and Amplification by Tailing and Switching (CATS). An ultrasensitive ligation-independent method for generation of DNA libraries for deep sequencing from picogram amounts of DNA and RNA |
Q52730409 | Cell-free DNA in breast cancer: a long way to go. |
Q40074752 | Cell-free circulating DNA Integrity based on peripheral blood as a biomarker for diagnosis of cancer: a systematic review |
Q40043175 | Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence |
Q24603537 | Characterization of extracellular circulating microRNA |
Q40571462 | Check and mate to exosomal extracellular miRNA: new lesson from a new approach |
Q48230033 | Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer |
Q34297783 | Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer |
Q40965602 | Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis |
Q54294896 | Circulating microRNAs in plasma as early detection markers for breast cancer. |
Q37368000 | Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q34002454 | Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk |
Q36403891 | Copy number variation in patients with cervical artery dissection |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q57191514 | DNA methylation array analyses identified breast cancer-associatedHYAL2methylation in peripheral blood |
Q37665624 | DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA. |
Q51780977 | Death receptor 4 variants and colorectal cancer risk. |
Q36552828 | Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma |
Q55007492 | Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals. |
Q35009015 | Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases |
Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
Q39124540 | Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts |
Q30245610 | Extracellular miRNA: A Collision of Two Paradigms |
Q44235487 | Extracellular miRNAs: the mystery of their origin and function |
Q35052285 | F2RL3 methylation as a biomarker of current and lifetime smoking exposures |
Q34649151 | F2RL3 methylation in blood DNA is a strong predictor of mortality |
Q44021766 | F2RL3 methylation, lung cancer incidence and mortality |
Q35999309 | FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor |
Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
Q43165954 | FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer |
Q24301469 | Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency |
Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q34794063 | First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome |
Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q53585636 | Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. |
Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
Q40545184 | Genetic Variants in the Vitamin D Pathway, 25(OH)D Levels, and Mortality in a Large Population-Based Cohort Study |
Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q36070191 | Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer |
Q100426886 | Genetic variants in the regulatory T cell related pathway and colorectal cancer prognosis |
Q53291654 | Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
Q44752870 | Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk |
Q44202581 | Genetic variations in the vitamin D binding protein and season-specific levels of vitamin D among older adults |
Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
Q50174463 | Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier). |
Q92737473 | Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer |
Q45087021 | Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3. |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q54664157 | Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. |
Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q34094502 | Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease |
Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
Q53163641 | Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk. |
Q41840249 | HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q34729935 | Identification and evaluation of plasma microRNAs for early detection of colorectal cancer |
Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
Q44028747 | Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity |
Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
Q43223092 | Identification of frequent chromosome copy-number polymorphisms by use of high-resolution single-nucleotide-polymorphism arrays |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q46627824 | Identification of new acyl-CoA binding protein transcripts in human and mouse |
Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q43506703 | Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer |
Q38315168 | Isolation of circulating microRNA associated with RNA-binding protein |
Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q43255116 | Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients |
Q46711428 | MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia |
Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
Q40201374 | Metabolic shifts in residual breast cancer drive tumor recurrence |
Q41239086 | Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q37873226 | MicroRNA signatures: novel biomarker for colorectal cancer? |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q45174307 | Molecular and clinical characterization of an in frame deletion of uncertain clinical significance in the BRCA2 gene |
Q53553688 | Molecular genetic analysis of NBS1 in German melanoma patients. |
Q46943095 | Multicentre study of CASP8 polymorphisms in breast cancer |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q28181983 | Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases |
Q24601453 | Mutations in ROGDI Cause Kohlschütter-Tönz Syndrome |
Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
Q38597275 | No Association of Vitamin D Pathway Genetic Variants with Cancer Risks in a Population-Based Cohort of German Older Adults |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
Q33583309 | Nuclear receptor coregulator SNP discovery and impact on breast cancer risk |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
Q34085823 | Pancreatic cancer susceptibility loci and their role in survival |
Q56089175 | Pathway analysis of genetic variants in folate-mediated one-carbon metabolism-related genes and survival in a prospectively followed cohort of colorectal cancer patients |
Q38993983 | Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis |
Q40768670 | Plasma S100P level as a novel prognostic marker of metastatic breast cancer |
Q41035419 | Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer |
Q40579865 | Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer |
Q35032320 | Plasma microRNA panel for minimally invasive detection of breast cancer |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q48296505 | Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q43613530 | Polymorphisms in genes involved in GH1 release and their association with breast cancer risk |
Q80636308 | Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q56987671 | Preliminary Evidence of FABP2 A54T Polymorphism Associated with Reduced Risk of Type 2 Diabetes and Obesity in Women from a German Cohort |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
Q36009422 | RAD51B in Familial Breast Cancer |
Q46585200 | Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q38913971 | Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer |
Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
Q41641041 | S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer |
Q34369604 | SNP genotyping on a genome-wide amplified DOP-PCR template |
Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
Q40936032 | SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients |
Q80442969 | SNPs in ultraconserved elements and familial breast cancer risk |
Q34485182 | Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients |
Q34224330 | Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene |
Q61118451 | Shared heritability and functional enrichment across six solid cancers |
Q64004349 | Shared heritability and functional enrichment across six solid cancers |
Q34236472 | Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease |
Q24810703 | TP53-binding protein variants and breast cancer risk: a case-control study |
Q33535259 | Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells |
Q57319812 | Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families |
Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
Q33300099 | The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study |
Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
Q40234422 | The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies |
Q61443921 | The associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study |
Q57192415 | The functional genetic variant Arg324Gly of frizzled-related protein is associated with colorectal cancer risk |
Q38309964 | The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer |
Q45154642 | The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk |
Q47163164 | The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk. |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Q57265670 | The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain |
Q53639998 | The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer. |
Q33860650 | Tobacco-smoking-related differential DNA methylation: 27K discovery and replication |
Q33263818 | Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study |
Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
Q92994868 | Two truncating variants in FANCC and breast cancer risk |
Q39489381 | Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis |
Q53088630 | Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality. |
Q46521646 | c-MYC Asn11Ser is associated with increased risk for familial breast cancer |
Q45957040 | miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome. |
Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.